Pasar al contenido principal

NUEVAS HERRAMIENTAS MOLECULARES Y NANOMETRICA DIRIGIDAS A LA TERAPIA Y DIAGNOSTICO DEL CANCER

PID2023-152689OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

PSMA-targeted delivery of docetaxel in prostate cancer using small-sized PDA-based micellar nanovectors

  • Rosales-Barrios, Cristian
  • González-Sánchez, Zaida
  • Zuliani, Alessio
  • Jiménez-Vacas, Juan M.
  • Luque, Raul M
  • Pozo, David
  • Khiar, Noureddine
In this study, we present the first comparative analysis of active and passive drug delivery systems for docetaxel (DTX) in prostate cancer using supramolecular self-assembled micellar nanovectors. Specifically, we developed two novel micelles based on polydiacetylenic amphiphiles (PDA) for passive and active targeting. The active targeting micelles were designed with a prostate-specific membrane antigen (PSMA) ligand, ACUPA, to facilitate recognition by PSMA-positive cancer cells. These PDA-based micelles feature a well-defined structure with a hydrophobic PDA core and a surface functionalized with PEG, and for active targeting, ACUPA. Our micelles demonstrated excellent encapsulation capacity, significantly improving DTX solubility in water, a crucial factor for clinical drug use. In vitro studies confirmed the safety and cytotoxic profiles of both systems, with ACUPA-functionalized micelles showing notable internalization into PSMA-positive LNCaP cells, mediated through the PSMA-ACUPA interaction. In vivo imaging revealed preferential accumulation of ACUPA-functionalized nanomicelles in LNCaP xenograft tumors, suggesting enhanced retention via specific ACUPA-PSMA interactions and active uptake by LNCaP cells. Notably, Balb/c-Foxn1nu/nu early in vivo studies showed a marked reduction in tumor volume and tumor expression levels of proliferation, cell cycle progression, cell survival and anti-apoptotic markers with DTX-loaded micelles functionalized with ACUPA compared to those without ACUPA. Overall, our studies collect initial evidence regarding the feasibility of supramolecular self-assembly of ACUPA-PDA-based nanomicelles for PSMA-targeted drug chemotherapy delivery developments., Financial support was provided by the Spanish Ministry of Science and Innovation (Ref: PID2020-119949RB-I00 and PID2023-152689OB-I00 to NK; RTI2018-098432-B-100 to DP, PID2022-1381850B-I00 to RML), the Andalusian Ministry of Economy, Science and Innovation cofinanced by the European Regional Development Fund (ERDF) from FEDER and the European Social Fund (ESF) (PY20_00882 and CV20-04221 to NK, and postodoctoral fellowship “POSTDOC_21_00594” to AZ), the CSIC (CSIC-COV19-047 to NK), Andalusian Ministry of Health (PI-0232-2022 to ZGS and DP) and the PAIDI Program from the Andalusian Government (FQM-313 to NK). The COST action CA-18132 “Functional Glyconanomaterials for the Development of Diagnostic and Targeted Therapeutic Probe” is also acknowledged. ZGS holds a postdoctoral fellowship from the María Zambrano program (21-20073; Spanish Government, Ministry of Universities, NextGeneration EU). We also thank the Centre of Research Technology and Innovation of the University of Seville (CITIUS) for the use of TEM, HRMS and NMR facilities., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Assessing small-sized D-fructose-functionalized micelles for active targeting of triple-negative breast cancer

  • Castillejos, M. Carmen
  • Zuliani, Alessio
  • Cova, Camilla M
  • Caro, Carlos
  • Noriega, Livia Lopez
  • Comaills, Valentine
  • García-Martín, María L.
  • Gauthier, Benoit R.
  • Khiar, Noureddine
ATR: Active Transport and Retention; CH2Cl2: Dichloromethane; CMC: Critical Micelle Concentration; DAPI: 4′,6-Diamidino-2-Phenylindole; DIC: N,N′-Diisopropylcarbodiimide; DLS: Dynamic Light Scattering; DMF: Dimethylformamide; DMSO: Dimethyl Sulfoxide; DXT: Docetaxel; EPR: Enhanced Permeability and Retention; FACS: Fluorescence-Activated Cell Sorting; FRUC: D-fructose; GLUT5: Glucose Transporter type 5; H&E: Haematoxylin and Eosin; HPLC: High-Performance Liquid Chromatography; HRMS: High-Resolution Mass Spectrometry; IgG: Immunoglobulin G; NMR: Nuclear Magnetic Resonance; NR: Nile Red; PDA: Polydiacetylene; PCDA: Pentacosadiynoic Acid; PEG: Polyethylene Glycol; PBS: Phosphate Buffered Saline; ROI: Region of Interest; SD: Standard Deviation; TEM: Transmission Electron Microscopy; TFA: Trifluoroacetic Acid; THF: Tetrahydrofuran; TNBC: Triple-Negative Breast Cancer., Chemicals and CAS Registry Numbers . azide 12596-60-0, 14343-69-2 dimethyl sulfoxide 67-68-5 docetaxel 114977-28-5 fructose 30237-26-4, 57-48-7, 7660-25-5, 77907-44-9 Show more, Triple-negative breast cancer (TNBC) is one of the most aggressive and clinically challenging subtypes of breast cancer. Its high heterogeneity and lack of actionable molecular targets limit therapeutic options, leading to poor patient outcomes. Given the reported overexpression of the fructose transporter GLUT5 (Glucose Transporter type 5) in breast cancer cells, D-fructose (FRUC) has been proposed as a ligand for active targeting; however, its effectiveness remains uncertain. Here, we investigate passive and fructose-mediated active targeting of TNBC using small-sized supramolecular micelles in vitro and in vivo. We designed two micelle formulations, one incorporating a D-fructose headgroup, using amphiphiles composed of pentacosadiynoic acid as the hydrophobic core and polyethylene glycol as a spacer. These micelles (∼10 nm) were characterized by nuclear magnetic resonance, electron microscopy, and dynamic light scattering, and their stability was confirmed under various conditions. Cellular internalization studies, flow cytometry, and confocal microscopy revealed that PEGylated micelles exhibited superior intracellular accumulation compared to fructose-functionalized micelles, suggesting that D-fructose may hinder endocytic uptake rather than enhance it. In vivo biodistribution analysis in tumor-bearing mice showed similar tumor accumulation for both formulations, with FRUC-Mic exhibiting a transiently higher presence at 1-h post-administration, though this difference was not statistically significant. Although this study does not validate D-fructose as an effective ligand for active targeting, both micelle formulations showed key advantages, including Immunoglobulin G-sized particles, high stability, and facile synthesis, enabling scalable production and clinical translation. Moreover, their ability to solubilize, stabilize, and deliver hydrophobic dyes and cytotoxic agents underscores their potential as theranostic nanoplatforms for TNBC treatment., Financial support was provided by the Spanish Ministry of Science and Innovation (Ref: PID2020-119949RB-I00 and PID2023-152689OB-I00 to NK), the Andalusian Ministry of Economy, Science and Innovation cofinanced by the European Regional Development Fund (ERDF) from FEDER and the European Social Fund (ESF) (PY20_00882, CV20-04221 and “POSTDOC_21_00594”), the CSIC (CSIC-COV19-047) the PAIDI Program from the Andalusian Government (FQM-313). The COST action CA-18132 “Functional Glyconanomaterials for the Development of Diagnostic and Targeted Therapeutic Probe” is also acknowledged. Financial support was provided by the Andalusian Ministry of Economy, Science and Innovation in the framework of the Plan Andaluz de Investigación, Desarrollo e Innovación (PAIDI 2020, programme 54a “Investigación científica e innovación”, “POSTDOC_21_00594”), the Fundación Vencer el Cancer (B.R.G. and V.C), the Spanish association against the Cancer AECC investigator grant (INVES20033COMA to V.C.) and the Marie Skłodowska-Curie Individual Fellowship (MSCA-IF Onco-inflammation 101026137 to V.C.). In vivo and ex vivo optical/X-ray images were acquired at the ICTS “NANBIOSIS”, specifically within the U28 Unit at the Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)., Peer reviewed